Endogenous Hydrogen Sulphide Promotes the Ex Vivo Expansion of Haematopoietic Stem Cells by Regulating the Activation of the JAK2/STAT3 Pathway
- PMID: 40405487
- DOI: 10.1111/imm.13935
Endogenous Hydrogen Sulphide Promotes the Ex Vivo Expansion of Haematopoietic Stem Cells by Regulating the Activation of the JAK2/STAT3 Pathway
Abstract
Haematopoietic stem cell transplantation (HSCT) is one of the key strategies for treating various haematologic malignancies. Although there are haematopoietic stem cells (HSCs) in umbilical cord blood (UCB), the number is limited. Thus, the purpose of this work was to investigate if endogenous hydrogen sulphide (H2S) could encourage the ex vivo expansion of HSCs produced from UCB (UCB-HSCs). The CD34+ and CD34+CD38- cells were enriched and separated by immunomagnetic beads. UCB-HSCs were treated with overexpression plasmids of β-synthase (CBS), cystathionine γ-lyase (CSE), 3-mercaptopyruvate sulphurtransferase (MPST) and/or stimulated with AG490 (JAK2/STAT3 inhibitor) for 4, 7 or 10 days, respectively. The content of H2S in cells was detected using its assay kit. The proportion and quantity of CD34+, CD34+CD38- and CXCR4+CD34+ cells as well as the ALDH1A1+CD34+ cells in CD34+ cells were detected by flow cytometry. qPCR was used to detect the expression of CD34, CXCR4 and ALDH1A1 in CD34+ cells. Western blot was used to detect the activation of the JAK2/STAT3 pathway in CD34+ cells. The results showed that endogenous H2S enhanced the ex vivo expansion of CD34+ and CD34+CD38- cells, upregulated the expression of CXCR4 and ALDH1A1 during ex vivo expansion of HSCs, and promoted the JAK2/STAT3 pathway in CD34+ cells. However, the aforementioned effects of endogenous H2S were partially reversed by AG490. In conclusion, endogenous H2S promotes the activation of the JAK2/STAT3 pathway to facilitate the ex vivo expansion of UCB-HSCs.
Keywords: JAK2/STAT3 pathway; ex vivo expansion; haematopoietic stem cells; hydrogen sulphide; umbilical cord blood.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.Stem Cell Res Ther. 2024 Jul 29;15(1):234. doi: 10.1186/s13287-024-03830-0. Stem Cell Res Ther. 2024. PMID: 39075614 Free PMC article. Review.
-
Mesenchymal stem/stromal cells from human pluripotent stem cell-derived brain organoid enhance the ex vivo expansion and maintenance of hematopoietic stem/progenitor cells.Stem Cell Res Ther. 2024 Mar 5;15(1):68. doi: 10.1186/s13287-023-03624-w. Stem Cell Res Ther. 2024. PMID: 38443990 Free PMC article.
-
ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2/STAT3 signaling pathway.Sci Rep. 2025 Jul 1;15(1):22083. doi: 10.1038/s41598-025-06017-6. Sci Rep. 2025. PMID: 40594822 Free PMC article.
-
[Exploration of the mechanism of electroacupuncture at "Jiaji" (EX-B2) in treating neuronal apoptosis in rats with spinal cord injury based on the JAK2/STAT3 pathway].Zhen Ci Yan Jiu. 2025 Jun 25;50(6):633-640. doi: 10.13702/j.1000-0607.20240070. Zhen Ci Yan Jiu. 2025. PMID: 40551645 Chinese.
-
Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies.Transplant Cell Ther. 2023 Feb;29(2):129.e1-129.e9. doi: 10.1016/j.jtct.2022.11.007. Epub 2022 Nov 15. Transplant Cell Ther. 2023. PMID: 36396108
References
-
- V. Calvanese, A. T. Nguyen, T. J. Bolan, et al., “MLLT3 Governs Human Haematopoietic Stem‐Cell Self‐Renewal and Engraftment,” Nature 576, no. 7786 (2019): 281–286.
-
- J. L. Stolfi, C. C. S. Pai, and W. J. Murphy, “Preclinical Modeling of Hematopoietic Stem Cell Transplantation ‐ Advantages and Limitations,” FEBS Journal 283, no. 9 (2016): 1595–1606.
-
- F. Barriga, P. Ramírez, A. Wietstruck, and N. Rojas, “Hematopoietic Stem Cell Transplantation: Clinical Use and Perspectives,” Biological Research 45, no. 3 (2012): 307–316.
-
- E. A. Copelan, “Hematopoietic Stem‐Cell Transplantation,” New England Journal of Medicine 354, no. 17 (2006): 1813–1826.
-
- D. Averbuch, E. Horwitz, J. Strahilevitz, et al., “Colistin is Relatively Safe in Hematological Malignancies and Hematopoietic Stem Cell Transplantation Patients,” Infection 41, no. 5 (2013): 991–997.
MeSH terms
Substances
Grants and funding
- 202203040348/Medical and Health Technology Development Plan Project of Shandong Province
- ZR2022QH142/Natural Science Foundation of Shandong Province
- ZR2020QH005/Natural Science Foundation of Shandong Province
- ZR2021QH262/Natural Science Foundation of Shandong Province
- 2023FYQ007/Science and Technology Development Program of Weifang Medical University
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous